Keyword: Aricept

With plans for further expansion in China, Japan’s Eisai has opened a new solid dose plant in Suzhou.

Seniors and dementia patients in Japan can go out more safely thanks to a new tracking tool from Eisai.

After suffering key patent losses, Eisai's new cancer meds are critical to its rebound. But for the second time this summer, the Japanese drugmaker has hit a hurdle with Europe's cost watchdogs.